I make it a fairly regular habit of having a look at companies that care about their dividend. The dividend aristocrat list has always been a good starting place for me as these stocks have a proven track record of tailoring themselves to the dividend investor. Abbott Labs appears in the 2009 version of this list.
To put a full review of Abbott would make for a long post, and not a particularly interesting one, so I’ll instead restrict myself to looking at a few key elements from the company’s fundementals. Perhaps this will help to add to the research you have already performed on Abbott or suggest some alternative ways that you can look at other companies.
Read More...
I very much dislike intangible assets, the growth or continued presence of them on a balance sheet always throws up a red flag for me. Maybe it is due to my value investor perspective but giving financial credence to a resource that I can’t see, can’t touch and can’t prove generated a cent of revenue in a business is something I just don’t like.
Read More...
The author has taken all usual and reasonable precautions to determine that the information contained in this website has been obtained from sources believed to be reliable. However, the market forces underlying investment value are subject to sudden and dramatic changes affecting data availability and information may be available which is not reflected in this website. Consequently, the author makes any warranty as to the accuracy or completeness of information, analysis or views contained in this website or their usefulness or suitability in any particular circumstance. This website should not be relied upon for any investment or portfolio assessment or other transaction. Please consult your Investment Executive directly to review any proposed investment or transaction. The author accept no liability of whatsoever kind for any damages or losses incurred by you as a result of reliance upon or use of this website in contravention of this notice. Copyright 2008.